Delivery Order SPE2DB25D3110-SPE2DB25FTDNZ

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $27,404.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LAMICTAL XR 100 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,318.13 firm-fixed-price delivery order is for the supply of LAMICTAL XR 250 MG TABLET 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,493.27 firm fixed-price delivery order is for the supply of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,834.90 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S. The contract has an ultimate completion date of May 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,539.31, is for the delivery of Lamictal XR 300 mg tablets to support defense and civilian medical programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557859050 LAMICTAL XR 300 MG TABLET 30S. The $3,765.85 firm fixed-price contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,863.24 firm fixed-price delivery order contract is for the supply of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,262.23 and a period of performance through December 13, 2023. This Delivery Order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LAMICTAL XR 300 MG TABLET 30S. The $3,997.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply...
  • SPE2DB25D3110
    Indefinite Delivery Contract
  • SPE2DB25D3110-SPE2DB25FTDNZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order with a firm fixed price of $4,141.88 and a performance period ending on June 10, 2025.

The contract is for the delivery of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00. The IDC provides a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies, allowing Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside.

Generated 9/8/25, 9:47 AM